|
CNOT7 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.64257496493292E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.99582622335038E-12 |
| Normal-vs-Stage2 |
4.23750000000389E-05 |
| Normal-vs-Stage3 |
2.74402722766354E-12 |
| Normal-vs-Stage4 |
5.02975439076181E-12 |
| Stage1-vs-Stage2 |
3.581200E-01 |
| Stage1-vs-Stage3 |
4.834500E-02 |
| Stage1-vs-Stage4 |
2.079400E-03 |
| Stage2-vs-Stage3 |
3.343500E-02 |
| Stage2-vs-Stage4 |
4.960500E-03 |
| Stage3-vs-Stage4 |
3.015000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.90958360235527E-14 |
| Normal-vs-AfricanAmerican |
1.878750E-03 |
| Normal-vs-Asian |
1.42860000496015E-08 |
| Caucasian-vs-AfricanAmerican |
2.044600E-01 |
| Caucasian-vs-Asian |
9.545000E-01 |
| AfricanAmerican-vs-Asian |
3.382200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.55175872151858E-12 |
| Normal-vs-Female |
2.51165754860949E-12 |
| Male-vs-Female |
1.435020E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.39560055021104E-10 |
| Normal-vs-Age(41-60Yrs) |
3.85558251991824E-12 |
| Normal-vs-Age(61-80Yrs) |
3.5927039121475E-11 |
| Normal-vs-Age(81-100Yrs) |
4.363900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.596000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.220800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.731800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.513200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.925400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.759800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.032400E-02 |
| Classical-VS-Follicular |
8.562600E-01 |
| Classical-VS-Other |
4.009600E-01 |
| Classical-VS-Normal |
2.56209999882628E-08 |
| Tall-VS-Follicular |
3.250200E-02 |
| Tall-VS-Other |
7.868800E-01 |
| Tall-VS-Normal |
1.04480002427465E-09 |
| Follicular-VS-Other |
4.641200E-01 |
| Follicular-VS-Normal |
4.33119999976306E-07 |
| Other-VS-Normal |
3.783400E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.64039934150651E-11 |
| Normal-vs-N1 |
1.4701018180574E-11 |
| N0-vs-N1 |
3.252500E-02 |
|
|
